SHREE GANESH BIO-TECH (INDIA) LIMITED Financials Shree Ganesh Bio-Tech (India) Limited
Equities
SHREEGANES6
INE051N01026
Fishing & Farming
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.19 INR | 0.00% |
|
+2.59% | -33.89% |
Valuation
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 724.9 | 2,392 | 2,595 | 2,362 | 1,854 | 406.6 |
| Enterprise Value (EV) 1 | 726.5 | 2,393 | 2,597 | 2,364 | 1,853 | 401.8 |
| P/E ratio | 20.7 x | 134 x | 1,100 x | 746 x | 73.4 x | 20.4 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 9.23 x | 40.8 x | 105 x | 13.7 x | 2.55 x | 0.65 x |
| EV / Revenue | 9.25 x | 40.8 x | 105 x | 13.7 x | 2.55 x | 0.64 x |
| EV / EBITDA | 20.8 x | 134 x | 1,094 x | 334 x | 53.7 x | 18.7 x |
| EV / FCF | 79.1 x | -204 x | -237 x | 94.9 x | 58 x | 4.08 x |
| FCF Yield | 1.26% | -0.49% | -0.42% | 1.05% | 1.72% | 24.5% |
| Price to Book | 3.17 x | 4.18 x | 4.52 x | 4.09 x | 3.07 x | 0.65 x |
| Nbr of stocks (in thousands) | 36,624 | 3,98,624 | 3,98,624 | 3,98,624 | 3,98,624 | 3,98,624 |
| Reference price 2 | 19.79 | 6.000 | 6.510 | 5.925 | 4.650 | 1.020 |
| Announcement Date | 07/10/18 | 31/08/19 | 29/08/20 | 26/08/21 | 05/09/22 | 01/09/23 |
1INR in Million2INR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 78.58 | 58.68 | 24.73 | 172.1 | 726.4 | 624.5 |
| EBITDA 1 | 35.01 | 17.92 | 2.374 | 7.081 | 34.49 | 21.5 |
| EBIT 1 | 35.01 | 17.91 | 2.364 | 7.075 | 34.49 | 21.49 |
| Operating Margin | 44.55% | 30.51% | 9.56% | 4.11% | 4.75% | 3.44% |
| Earnings before Tax (EBT) 1 | 35 | 17.9 | 2.358 | 4.281 | 34.99 | 27.14 |
| Net income 1 | 35 | 17.9 | 2.358 | 3.168 | 25.26 | 20.39 |
| Net margin | 44.55% | 30.5% | 9.54% | 1.84% | 3.48% | 3.26% |
| EPS 2 | 0.9560 | 0.0449 | 0.005916 | 0.007946 | 0.0634 | 0.0500 |
| Free Cash Flow 1 | 9.18 | -11.76 | -10.97 | 24.9 | 31.96 | 98.45 |
| FCF margin | 11.68% | -20.03% | -44.35% | 14.46% | 4.4% | 15.76% |
| FCF Conversion (EBITDA) | 26.22% | - | - | 351.59% | 92.66% | 457.91% |
| FCF Conversion (Net income) | 26.23% | - | - | 785.98% | 126.54% | 482.88% |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 07/10/18 | 31/08/19 | 29/08/20 | 26/08/21 | 05/09/22 | 01/09/23 |
1INR in Million2INR
Estimates
Balance Sheet Analysis
| Fiscal Period: March | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 1.62 | 1.51 | 1.72 | 1.66 | - | - |
| Net Cash position 1 | - | - | - | - | 0.35 | 4.8 |
| Leverage (Debt/EBITDA) | 0.0463 x | 0.0841 x | 0.7262 x | 0.2346 x | - | - |
| Free Cash Flow 1 | 9.18 | -11.8 | -11 | 24.9 | 32 | 98.4 |
| ROE (net income / shareholders' equity) | 16.6% | 4.47% | 0.41% | 0.55% | 4.28% | 3.32% |
| ROA (Net income/ Total Assets) | 9.55% | 2.47% | 0.23% | 0.63% | 2.56% | 1.55% |
| Assets 1 | 366.4 | 723.3 | 1,028 | 499.2 | 985.4 | 1,313 |
| Book Value Per Share 2 | 6.240 | 1.440 | 1.440 | 1.450 | 1.510 | 1.560 |
| Cash Flow per Share 2 | 0.0100 | 0 | 0 | 0 | 0 | 0.0100 |
| Capex 1 | 0.02 | 0.06 | - | - | - | - |
| Capex / Sales | 0.02% | 0.1% | - | - | - | - |
| Announcement Date | 07/10/18 | 31/08/19 | 29/08/20 | 26/08/21 | 05/09/22 | 01/09/23 |
1INR in Million2INR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -33.89% | 5.68M | |
| +8.75% | 2.08B | |
| -8.95% | 1.77B | |
| +2.64% | 1.35B | |
| -0.18% | 1.06B | |
| -10.61% | 1.05B | |
| -8.59% | 1.02B | |
| -18.37% | 926M | |
| +10.60% | 752M | |
| -4.71% | 431M |
- Stock Market
- Equities
- SHREEGANES6 Stock
- Financials Shree Ganesh Bio-Tech (India) Limited
